EvolveImmune Therapeutics

EvolveImmune Therapeutics

Biotechnology Research Branford, Ct, United States 54 employees
Employees
54
Contacts
3
Emails
3
Phones
1

EvolveImmune Therapeutics Overview

Headquarters
Branford, Ct, United States
Phone Number
Available in AeroLeads
Industry
Biotechnology Research
Employees
54
Founded
2020
Funding
20.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About EvolveImmune Therapeutics

EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation. The EVOLVE platform tackles the treatment challenges of cancer cell resistance to current immunotherapies. The company’s lead internal drug candidate, EVOLVE104, will enter the clinic in 2025. We are based in Branford, CT.

EvolveImmune Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

EvolveImmune Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Hemachander Capiralla
Email
Mark Aimone, Mba Senior Vice President - Cmc Leadership
Email Phone
Michelle Baptiste, Sphr, Shrm-Scp Human Resources Leader Partnering
Email
Charlene Cormier Senior Talent Acquisition Leader
View

Employees by Management Level

Individual contributor 9 profiles
Senior / Lead 3 profiles
Executive 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 5 5 0
IT 1 1 0

EvolveImmune Therapeutics Tech Stack

Data / AI 3 profiles
Engineering 1 profile

Compare Similar Companies to EvolveImmune Therapeutics